Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
It is evident from the numerous inquiries that are received at the Willard Parker Hospital that the true value of scarlet fever antitoxin is not generally known; with this in view, the following observations are presented. The series presented consists of 465 consecutive and unselected cases, in which 250 of the patients did not receive antitoxin. I feel, therefore, that the real value of the antitoxin can be obtained. All patients with scarlet fever who were admitted to the hospital did not receive antitoxin, for it was apparent that in the moderately severe and in the mild cases the patients did not show sufficient toxemia to warrant the treatment. Furthermore, the serum rash that may appear often causes more subjective symptoms than the disease per se. Therefore, it was decided that the temperature and the clinical observations should govern the administration of the antitoxin. As a rule, patients who had
American journal of diseases of children – American Medical Association
Published: Jan 1, 1928
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.